Sharon M Tennants

Title: The Innovative Contributions of Sharon M. Tennants

Introduction

Sharon M. Tennants is a notable inventor based in Baltimore, MD (US). She has made significant contributions to the field of vaccine development, particularly through her innovative research on bacterial conjugate vaccines. Her work focuses on enhancing the efficacy of vaccines by utilizing advanced methodologies in microbiology.

Latest Patents

Sharon M. Tennants holds a patent for "Compositions and methods for producing bacterial conjugate vaccines." This invention involves the production of longer chain antigenic O-polysaccharide chains using recombinant Gram-negative bacteria that overexpress specific genes. The bacteria can produce lipopolysaccharides with modified O-polysaccharide chain lengths, which are crucial for developing effective vaccines. The patent outlines the process of hydrolyzing the lipopolysaccharides to create core-O-polysaccharide molecules that can be conjugated to carrier molecules, such as flagellin, to produce a vaccine. This innovative approach also includes the development of recombinant bacteria, polysaccharide molecules, conjugated vaccines, pharmaceutical compositions, and kits.

Career Highlights

Sharon M. Tennants is affiliated with the University System of Maryland, where she conducts her research and development work. Her career is marked by a commitment to advancing vaccine technology and improving public health outcomes through innovative scientific research.

Collaborations

Sharon has collaborated with esteemed colleagues, including Myron M. Levine and Raphael Simon, who share her dedication to vaccine research and development. Their combined expertise contributes to the advancement of knowledge in the field.

Conclusion

Sharon M. Tennants is a pioneering inventor whose work in bacterial conjugate vaccines represents a significant advancement in immunology. Her innovative approaches and collaborations continue to impact the field positively.